Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Strides Pharma Science Limited is a global pharmaceutical company based in Bengaluru, India. It focuses on manufacturing and exporting a wide range of generic and branded pharmaceutical products.
In Q3FY26, the company achieved its highest ever EBITDA of ₹2,359 million, reflecting a 12.2% year-over-year increase, demonstrating strong operational performance.
Despite a modest revenue growth of 3.6%, the company saw an exceptional 38.6% increase in operational PAT, driven by strong performance in Ex-US markets, which grew by 20% YoY.
The Ex-US markets are becoming increasingly significant, now contributing to 47% of revenue, indicating a strategic shift in the company’s geographical revenue distribution.
Strides Pharma's balance sheet has strengthened, with a reduction in net debt due to effective cash flow management and a focus on high-margin products.
Pharmaceuticals & Biotechnology
Pharmaceuticals
10,591 Cr
Low Risk
16.7
37.4
0.8
3.5
1,231.45
769.60
Sales CAGR
Profit CAGR
ROE
ROCE
Strides Pharma Science Ltd (STAR) is currently trading at 1,149.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Strides Pharma Science Limited is a global pharmaceutical company based in Bengaluru, India. It focuses on manufacturing and exporting a wide range of generic and branded pharmaceutical products. In Q3FY26, the company achieved its highest ever EBITDA of ₹2,359 million, reflecting a 12.2% year-over-year increase, demonstrating strong operational performance. Despite a modest revenue growth of 3.6%, the company saw an exceptional 38.6% increase in operational PAT, driven by strong performance in Ex-US markets, which grew by 20% YoY. The Ex-US markets are becoming increasingly significant, now contributing to 47% of revenue, indicating a strategic shift in the company’s geographical revenue distribution. Strides Pharma's balance sheet has strengthened, with a reduction in net debt due to effective cash flow management and a focus on high-margin products.
Over the past 52 weeks, Strides Pharma Science Ltd has traded between a low of ₹769.60 and a high of ₹1,231.45. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Strides Pharma Science Ltd has a market capitalization of approximately 10,932.61. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Strides Pharma Science Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 17.23 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 10,932.61 Cr, Strides Pharma Science Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Strides Pharma Science Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Strides Pharma Science Ltd is 17.23. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Strides Pharma reported consolidated revenue of ₹1,265.40 crore (₹12,654 million) in Q1 FY27, up 13% year-on-year.
Revenue from operations rose 13.0% year-on-year to ₹12,654.07 million in Q1 FY27.
Strides Pharma Science reported consolidated reported PAT of ₹165.49 crore in Q1 FY27, a 56.7% increase year-on-year.
FY26 consolidated revenue was ₹48,587 million, up 6.4% year-on-year. The company said underlying growth excluding access markets was about 10%.
Discovery themes featuring this stock
Bearish
3
Neutral
6
Bullish
5
Bearish
10
Neutral
6
Bullish
30
Bearish
7
Neutral
0
Bullish
25
Bearish
3
Neutral
6
Bullish
5
Bearish
3
Neutral
6
Bullish
5
Bearish
7
Neutral
0
Bullish
25
Bearish
7
Neutral
0
Bullish
25
Bearish
7
Neutral
0
Bullish
25
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1211.05 | 13,561 Cr | 73.86 | 15.35 | 0.00 | 19.57 | 22.16 | 15.63 | ||
776.20 | 12,217 Cr | 41.74 | 3.69 | 0.38 | 7.70 | 10.95 | 5.37 | ||
257.00 | 11,332 Cr | 53.01 | 4.02 | 0.00 | 7.07 | 13.01 | 5.77 | ||
1185.85 | 10,933 Cr | 17.23 | 3.52 | 0.42 | 17.90 | 17.30 | 9.16 | ||
569.60 | 10,753 Cr | 45.77 | 4.98 | 0.19 | 18.22 | 24.16 | 14.31 | ||
4044.00 | 9,302 Cr | 34.97 | 26.74 | 1.85 | 76.46 | 92.74 | 37.66 | ||
5405.00 | 8,981 Cr | 25.16 | 17.12 | 3.79 | 62.32 | 84.14 | 42.42 | ||
| Median: 7 Co. | — | 1185.85 | 10,933 Cr | 41.74 | 4.98 | 0.38 | 18.22 | 22.16 | 14.31 |
